Back HIV R4P and CONRAD
October 6, 2014
HIV R4P is the world’s first and only scientific meeting dedicated exclusively to biomedical HIV prevention research and it’s happening October 28-30, 2014 in Cape Town, South Africa. CONRAD is a sponsor of the conference and our scientists will be making a number of presentations, as well as hosting a pre-conference satellite session with AVAC on Monday, October 27th from 1:30-5:00pm – “The Road to Adherence: Lessons Learned, Barriers and Drivers, Innovative Solutions”. Click on the attachment below to view the full agenda.
Our presenters and presentations include:
MEREDITH CLARK, PHD – CONRAD MANAGER, DRUG DELIVERY
Tuesday, October 28th – 11:15am – Oral abstract: “Tenofovir Reservoir Intravaginal Rings Provide Superior Pharmacokinetics and Higher Sustained Drug Levels than Tenofovir Matrix Rings”
Wednesday, October 29th – 10:00am and 5:00pm – Poster presentation: “Overcoming Phase Behavior and Surface Crystallization in a Tenofovir-levonorgestrel Intravaginal Ring”
GUSTAVO DONCEL, PH.D, MD – CONRAD AND EXECUTIVE DIRECTOR
Wednesday, October 29th – 1:30-5:00pm – Chair, Oral Abstract Session: Evaluation of Novel Biomedical Interventions
JILL SCHWARTZ, MD – CONRAD MEDICAL DIRECTOR
Wednesday, October 29th – 11:30am – Oral abstract: “Multicompartmental Pharmacokinetics of Tenofovir 1% Gel Using the BAT 24 Regimen Versus Daily and Single Pericoital Dosing”
4:15pm – “Novel On-Demand Vaginal Microbicide Formulations: Tablets and Films”
ANDREA THURMAN, MD – EVMS ASSOCIATE PROFESSOR OF OBGYN
Tuesday, October 28th – 2:30pm – Oral abstract: “Effect of Bacterial Vaginosis on Markers of Genital Tract Inflammation and Mucosal Immunity: Mechanisms for Susceptibility to HIV infection”:
Wednesday, October 29th – 10:00am and 5:00pm – Poster presentation: “Assessment of the Vaginal Residence Time of Biomarkers of Semen Exposure”
Thursday, October 30th – 10:00am and 5:00pm – Poster presentation: “Mucosal Susceptibility to HIV-1 and Tenofovir Protection in Explanted Cervicovaginal Tissues from Postmenopausal compared to Premenopausal Women”
IRINA ZALENSKAYA, PHD – EVMS ASSISTANT PROFESSOR
Thursday, October 30th – 10:00am and 5:00pm – Poster presentation: “Gene Expression Analysis of Human Vaginal Mucosal Response to Pro-inflammatory Stimuli – Identification of Biomarkers of Vaginal Inflammation”
ADDITIONAL PRESENTATIONS WITH CONRAD CONTRIBUTORS:
Wednesday, October 29th – 11:45 – 12:00: Population Pharmacokinetic Model of Vaginal Tenofovir 1% Gel in the Cervicovaginal Fluid – Kuo-Hsiung Yang1, Jill L. Schwartz2, Craig Sykes1, Gustavo F. Doncel2, Angela D.M. Kashuba1
Thursday, October 30th – 5:25 – 5:35: “He Said, She Said.” Exploring Couples’ Sensory Perceptions and Experiences with Vaginal Gels & Film: Implications for Microbicide Development – Kathleen M. Morrow1, Rochelle K. Rosen2, Joseph L. Fava3, Lisa Rohan4, Erna M. Kojic5, David Friend6, David Katz7, Robert Buckheit8
Posters
Wednesday, 29 October: Biomarkers of Cervical Inflammation and Immunity Associated with Cervical HIV-1 RNA – Presenter: Raina Fichorova, CONRAD contributors: Christine Mauck and Andrea Thurman
Wednesday, 29 October: MZC and 1% TFV Gel: Multipurpose Prevention Approaches, Presenter: José Fernández-Romero, CONRAD Contributors: Meredith Clark and Gustavo Doncel
Thursday, 30 October: Obstetric and Infant Outcomes Following Planned Maternal Third Trimester Exposure to Tenofovir 1% Vaginal Gel – Presenter: Lisa Noguchi, CONRAD contributor: Jill Schwartz